Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967862 · ClinicalTrials.gov registry record · NA
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer
A NA study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT01967862 is a NA study that has completed, run by City of Hope Medical Center. The registered enrollment target is 54 participants.
The verdict
NCT01967862, a NA study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This phase II trial studies how well fluorine F 18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) and whole body and axial magnetic resonance imaging (MRI) work in finding metastases in patients with recurrent prostate cancer. New imaging techniques, such as fluorine F 18 sodium fluoride PET/CT and whole body and axial MRI, may be more effective than standard CT and bone scan in finding metastatic prostate cancer.
Interventions
- PROCEDURE computed tomography
- PROCEDURE diffusion-weighted magnetic resonance imaging
- PROCEDURE 3-Tesla magnetic resonance imaging
- RADIATION fluorine F 18 sodium fluoride
- PROCEDURE bone scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2013-12 |
| Est. Completion | 2018-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01967862
The ClinicalTrials.gov registry entry for NCT01967862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which computed tomography is the first listed.
NCT01967862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01967862 about?
NCT01967862 is a clinical study titled "Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer". This phase II trial studies how well fluorine F 18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) and whole body and axial magnetic resonance imaging (MRI) work in finding metastases in patients with recurrent prostate cancer. New imaging techniques, such as fluorine F 1...
What is the current status of trial NCT01967862?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2013-12. Estimated completion is 2018-09-17.
What interventions are being tested in trial NCT01967862?
The interventions under investigation include: computed tomography (PROCEDURE), diffusion-weighted magnetic resonance imaging (PROCEDURE), 3-Tesla magnetic resonance imaging (PROCEDURE), fluorine F 18 sodium fluoride (RADIATION), bone scan (PROCEDURE).
Who is sponsoring clinical trial NCT01967862?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.